Literature DB >> 8822656

A prospective study of high- versus low-dose oxytocin for induction of labor.

A Hourvitz1, M Alcalay, J Korach, A Lusky, G Barkai, D S Seidman.   

Abstract

BACKGROUND: To assess the efficacy and safety of a high-dosage oxytocin induction regimen.
METHODS: A randomized prospective study of 179 patients who received an initial dose of either 2.5 (n = 98) or 1.25 (n = 81) mU/minute of oxytocin, with increments of 2.5 mU/minute or 1.25 at 30-minute intervals.
RESULTS: Failure rates (15.3% versus 19.8%), time to delivery, the number of assisted vaginal deliveries, cesarean sections, and maternal and fetal complications were not significantly different in the two protocols. However, the use of a high oxytocin dose resulted in significantly higher mean peak doses and increased total cumulative amounts. These were associated with a significant need to modify the oxytocin infusion protocol for hyperstimulation and fetal heart rate changes (65.1% versus 46.2%).
CONCLUSIONS: Induction with higher dose oxytocin increments did not shorten time to delivery, but was associated with an increase in uterine hyperstimulation. Low-dose oxytocin was found to be appropriate and safe for labor induction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822656     DOI: 10.3109/00016349609054688

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Stopping Oxytocin in Active Labor Rather Than Continuing it until Delivery: A Viable Option for the Induction of Labor.

Authors:  Seema Chopra; Sandip K SenGupta; Vanita Jain; Parveen Kumar
Journal:  Oman Med J       Date:  2015-09

Review 2.  Intravenous oxytocin alone for cervical ripening and induction of labour.

Authors:  Zarko Alfirevic; Anthony J Kelly; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

Review 3.  High-dose versus low-dose oxytocin infusion regimens for induction of labour at term.

Authors:  Aaron Budden; Lily J Y Chen; Amanda Henry
Journal:  Cochrane Database Syst Rev       Date:  2014-10-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.